Schedule 13G ownership disclosure

HERON THERAPEUTICS, INC.

Security class unavailable · CUSIP: 427746102

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,577,871
Percent of class
5.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-19-000304
Form type
SC 13G
Filer
HERON THERAPEUTICS, INC. /DE/
CIK
CIK 818033
Filed
Feb 12, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub